ERIN DODSON: Open Payments
NPI 1346661428 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$309 in 16 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $94 · 2025 $309
Food & beverage: $309
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $137 |
| BETA BIONICS, INC. | 1 | $34 |
| Novo Nordisk Inc | 2 | $30 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $28 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Corcept Therapeutics | 1 | $16 |
| Astellas Pharma US Inc | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Merck Sharp & Dohme LLC | 1 | $14 |
Products named: BREZTRI, AIRSUPRA, iLet Bionic Pancreas, XIFAXAN, CAPLYTA, Korlym, Ozempic, Veozah.
Industry payments across IN — which companies pay providers there.
